Clinical trial
Assessment of Cognitive Function and Mobility in Individuals With Pain
NCT02974114 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Cognitive Function and Mobility in Individuals With Pain
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 31, 2016
- Completion date
- February 6, 2017
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.